14
Neonatal Abstinence Syndrome Karen Estrella-Ramadan 06/25/2012

Neonatal Abstinence Syndrome

  • Upload
    luna

  • View
    79

  • Download
    1

Embed Size (px)

DESCRIPTION

Neonatal Abstinence Syndrome. Karen Estrella-Ramadan 06/25/2012. Acute use of heroin and other opioids stimulate opiate receptors in the brain which may result in symptoms including euphoria, resp depression, analgesia and nausea. - PowerPoint PPT Presentation

Citation preview

Page 1: Neonatal Abstinence Syndrome

Neonatal Abstinence SyndromeKaren Estrella-Ramadan06/25/2012

Page 2: Neonatal Abstinence Syndrome

• Acute use of heroin and other opioids stimulate opiate receptors in the brain which may result in symptoms including euphoria, resp depression, analgesia and nausea.

• Chronic use of opioids s associated with tolerance, which later leads to dependence, whereby the neurochemical balance in the CNS is altered and absence of the drugs leads to withdrawal syndrome

Page 3: Neonatal Abstinence Syndrome

Opioids and pregnancy• Repetitive use and withdrawal leads to ftal hypoxia, fetal

demise, IUGR, SGA• Medication-assisted tx with methadone• Long half life• With advance pregnancy is metabolized faster and higher doses

are required

Page 4: Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome• Timing– Heroin: 48-72hrs– Methadone: 4 days

• Screening:– Newborn urine:

• 24-48hrs• Amphetamines, barbiturates, benzos, cocaine, marijuana, some

opioids-my not include methadone or oxycodone

– Meconium toxicology• First 3-4 days• Ampehtamines, opiods, cocaine, marijuana

Page 5: Neonatal Abstinence Syndrome

Clinical FeaturesNEUROLOGICAL:•Tremors•Irritability•Increased wakefulness•High-pitched crying•Increased muscle tone•Hyperactive deep tendon reflexes•Exaggerated Moro reflex•Seizures•Frequent yawning and sneezing

GI DYSFUNCTION:•Poor feeding•Uncoordinated and constant sucking•Vomiting•Diarrhea•Dehydration•Poor weight gainAUTONOMIC SIGNS: •Increased sweating•Nasal stuffiness•Fever•Mottling•Temperature instability

Page 6: Neonatal Abstinence Syndrome

Treatment

• ~50-70% of infants will require tx• At delivery, NO naloxone= seizures• SCORING (modified Finnegan)• Before feeding

Page 7: Neonatal Abstinence Syndrome
Page 8: Neonatal Abstinence Syndrome
Page 9: Neonatal Abstinence Syndrome

1. Supportive• Encourage maternal and paternal involvement• Decrease stimulation: no light, no loud sounds, examination• Swaddling, soothing, rocking (vertical)• Non-nutritive sucking: Pacifier• Skin-skin contact: Kangaroo care• Skin care: lotion to areas of abrassion• Frequent feedings: increase caloric intake (150-250

cal/kg/day)• May allow BF if neg Utox in mother, HIV neg

Page 10: Neonatal Abstinence Syndrome

2. Pharmacological• Scoring >9 (x3: before and after feeding) or 2 >than 12• Short acting opioid: MORPHINE (0.4 mg/ml)– Start with 0.03 mg/kg/day

• 0.2 mg po q4hrs– Scoring: q8-12hrs

– If still high: increase by 0.16mg/kg/day q3hrs (max 0.8mg/kg/day)– Monitor:

– Over-sedation, decreased arousal, resp depression– Wean after 48hrs on scores <6

• Decrease 20% of daily dose• Continue scoring

– Wean after 28-72hrs on scores <6, and less freq feedings• Decrease 20% of daily dose

– d/c morphine– Once sub therapeutic dose is achieved, observe for 24-28 hrs off morphine– If sz: diff dx workup

– Add phenobarbital if no control of symptoms with max dosing

Page 11: Neonatal Abstinence Syndrome

Discharge• Off morphine for 24hrs with score <6• Adequate nutrition• No more than 10% wt loss

• SW clearance• f/u with PMD

Page 12: Neonatal Abstinence Syndrome

Other things to consider• Screens for:• Syphilis• Hepatitis B• Hepatitis C• HIV• Tb• DV

Page 13: Neonatal Abstinence Syndrome

Differential dx• Sepsis• Hypoglycemia• Hypocalcemia• hypomagnesemia

• Hyperthyroidism• Perinatal asphyxia• IVH

Page 14: Neonatal Abstinence Syndrome

References• http://www.uvm.edu/medicine/vchip/documents/VCHIP_5NE

ONATAL_GUIDELINES.pdf (University of Vermont)

• http://nctnc.org/workfiles/NAS.pdf (University of Connecticut)• NICU-SBH• http://pediatrics.aappublications.org/content/101/6/1079.full